Neuromuscular choristoma of the sciatic nerve in a child: description of clinical observation and brief literature review
https://doi.org/10.21682/2311-1267-2024-11-2-108-111
Abstract
The casuistry of benign triton tumor/neuromuscular choristoma (NMC) in the world medical literature has no more than 40–50 observations. There are no descriptions of a such disease in Russian sources. Here is our own case. A 6-year-old boy was diagnosed with a benign tumor of the right sciatic nerve. Sciatic neurolysis and removal of the neoplasm with a size of 8 × 3 × 3 cm were performed. Histological and immunohistochemical investigation revealed a tumor built of bundles of striated muscles and nerve fibers intertwined in the collagen matrix. Conclusion: benign triton tumor (NMC).
NMC is an extremely rare neoplasm associated with large nerves and occurs more often in childhood. Pain syndrome/neuropathy is usually clinically registered. Although a mature triton tumor is considered benign, it often has recurrences and desmoid fibromatosis (mainly postoperative): it is assumed that trauma stimulates fibroblasts/myofibroblasts with a mutation of the CTNNB1 gene. For this reason, noncontact diagnosis is recommended for patients with classic clinical and radiological signs of NMC. To develop an optimal approach to the treatment of this tumor and to assess the long-term prognosis of the disease, it is necessary to accumulate a sufficient number of observations.
About the Authors
D. P. KovtunRussian Federation
Cand. of Sci. (Med.), Pathologist, Head of the Central Pathological Department of General Pathology of the Leningrad Region
7 Santiago de Cuba St., Saint Petersburg, 194291
O. G. Polushin
Russian Federation
Cand. of Sci. (Med.), Pathologist of the Central Pathological Department of General Pathology of the Leningrad Region
7 Santiago de Cuba St., Saint Petersburg, 194291
A. A. Bublikova
Russian Federation
Pathologist of the Central Pathological Department of General Pathology of the Leningrad Region
7 Santiago de Cuba St., Saint Petersburg, 194291
E. V. Shcherbakova
Russian Federation
Pathologist of the Central Pathological Department of General Pathology of the Leningrad Region
7 Santiago de Cuba St., Saint Petersburg, 194291
O. E. Zenko
Russian Federation
Pathologist of the Central Pathological Department of General Pathology of the Leningrad Region
7 Santiago de Cuba St., Saint Petersburg, 194291
V. P. Snishchuk
Russian Federation
Neurosurgeon; Chief Specialist of the Leningrad Region Health Committee for Pediatric Neurosurgery
6 Komsomol St., Saint Petersburg, 195009
D. A. Ter-Abramov
Russian Federation
Neurosurgeon
6 Komsomol St., Saint Petersburg, 195009
References
1. Perry A. Bening triton tumour/neuromuscular choristoma. In: WHO Classifi cation of Tumours Editorial Board. Soft tissue and bone tumors. Lyon (France): International Agency for Research on Cancer; 2020 (WHO classifi cation of tumours series, 5th ed.; vol. 3). Pp. 249–251.
2. Masson P. Experimental and spontaneous schwannomas (peripheral gliomas). Am J Pathol. 1932;8:367–88. PMID: 19970026.
3. Kovtun D.P., Polushin O.G., Ponomareva E.V., Mironov T.A., Drobyshevsky D.V., Kolomoytsev S.V., Alrkseev D.A., Yurina K.V. A malignant triton tumor associated with a disease caused by the human immunodefi ciency virus. Prakticheskaya onkologiya = Practical Oncology. 2018;19(4):397–400. (In Russ.)
4. Awasthi D., Kline D.G., Beckman E.N. Neuromuscular hamartoma (benign “triton” tumor) of the brachial plexus. J Neurosurg. 1991;75(5):795–7. doi: 10.3171/jns.1991.75.5.0795.
5. Diagnostic pathology. Soft tissue tumors. Lindberg M.R., ed. 2nd ed. Philadelphia, PA: Elsevier, 2016. Pp. 550–551.
6. Thakrar R., Robson C.D., Vargas S.O., Meara J.G., Rahbar R., Smith E.R. Benign triton tumor: multidisciplinary approach to diagnosis and treatment. Pediatr Dev Pathol. 2014;17(5):400–5. doi: 10.2350/14-04-1459-CR.1.
7. Peng S., Behbahani M., Sharma S., Speck S., Wadhwani N.R., Rastatter J.C., Alden T.D. Pediatric benign triton tumor of trigeminal nerve: a case report and literature review. Childs Nerv Syst. 2022;38(11):2055–61. doi: 10.1007/s00381-022-05641-1.
8. Akimoto J., Fukami S., Hashimoto R., Haraoka J. Neuromuscular hamartoma is a possible primary pathology of oculomotor ophthalmoplegic migraine. Cephalalgia. 2012;32(2):171–4. doi: 10.1177/0333102411431331.
9. Coli A., Novello M., Tamburrini G., Antonelli M., Guangaspero F., Lauriola L. Intracranial neuromuscular choristoma: report of a case with literature review. Neuropathology. 2017;37(4):341–5. doi: 10.1111/neup.12368.
10. Zhao W., Zhu X. A case of esophageal neuromuscular choristoma. BMC Gastroenterol. 2022;22(1):180. doi: 10.1186/s12876-022-02249-2.
11. Park J.E. Long-term natural history of a neuromuscular choristoma of the sciatic nerve: a case report and literature review. Clin Imaging. 2019;55:18–22. doi: 10.1016/j.clinimag.2019.01.003.
12. Carter J.M., Howe B.M., Hawse J.R., Giannini C., Spinner R.J., Fritchie K.J. CTNNB1 mutations and estrogen receptor expression in neuromuscular choristoma and its associated fi bromatosis. Am J Surg Pathol. 2016;40(10):1368–74. doi: 10.1097/PAS.0000000000000673.
13. Rekhtman N., Baine M.K., Bishop J.A. Quick reference handbook for surgical pathologists. 2nd ed. Switzerland: Springer Nature Switzerland AG, 2019. doi: 10.1007/978-3-319-97508-5.
14. Hebert-Blouin M.N., Scheithauer B.W., Amrami K.K., Durham S.R., Spinner R.J. Fibromatosis: a potential sequela of neuromuscular choristoma. J Neurosurg. 2012;116(2):399–408. doi: 10.3171/2011.6.JNS102171.
15. Broski S.M., Howe B.M., Spinner R.J., Amrami K.K. Fibromatosis associated with neuromuscular choristoma: Evaluation by FDG PET/CT. Clin Nucl Med. 2017;42(3):e168–70. doi: 10.1097/RLU.0000000000001508.
Review
For citations:
Kovtun D.P., Polushin O.G., Bublikova A.A., Shcherbakova E.V., Zenko O.E., Snishchuk V.P., Ter-Abramov D.A. Neuromuscular choristoma of the sciatic nerve in a child: description of clinical observation and brief literature review. Russian Journal of Pediatric Hematology and Oncology. 2024;11(2):108-111. (In Russ.) https://doi.org/10.21682/2311-1267-2024-11-2-108-111